359 related articles for article (PubMed ID: 24447345)
21. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
Vyas SP; Goswami R
Front Immunol; 2018; 9():1139. PubMed ID: 29881387
[TBL] [Abstract][Full Text] [Related]
22. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
23. Th9 cells in inflammatory bowel diseases.
Weigmann B; Neurath MF
Semin Immunopathol; 2017 Jan; 39(1):89-95. PubMed ID: 27837255
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6--a key regulator of colorectal cancer development.
Waldner MJ; Foersch S; Neurath MF
Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
[TBL] [Abstract][Full Text] [Related]
25. Mucins in inflammatory bowel diseases and colorectal cancer.
Sheng YH; Hasnain SZ; Florin TH; McGuckin MA
J Gastroenterol Hepatol; 2012 Jan; 27(1):28-38. PubMed ID: 21913981
[TBL] [Abstract][Full Text] [Related]
26. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
27. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer.
Li Y; de Haar C; Peppelenbosch MP; van der Woude CJ
Cytokine Growth Factor Rev; 2012 Jun; 23(3):127-38. PubMed ID: 22591635
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-374b-5p and miRNA-106a-5p are related to inflammatory bowel disease via regulating IL-10 and STAT3 signaling pathways.
Li D; Liu L; Du X; Ma W; Zhang J; Piao W
BMC Gastroenterol; 2022 Nov; 22(1):492. PubMed ID: 36437465
[TBL] [Abstract][Full Text] [Related]
29. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
Li Y; Deuring J; Peppelenbosch MP; Kuipers EJ; de Haar C; van der Woude CJ
Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
[TBL] [Abstract][Full Text] [Related]
30. Emerging immunological targets in inflammatory bowel disease.
Monteleone G; Pallone F; MacDonald TT
Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
[TBL] [Abstract][Full Text] [Related]
31. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
Neurath MF; Finotto S
Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
[TBL] [Abstract][Full Text] [Related]
32. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
33. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis.
Gerlach K; Daniel C; Lehr HA; Nikolaev A; Gerlach T; Atreya R; Rose-John S; Neurath MF; Weigmann B
Cancer Res; 2012 Sep; 72(17):4340-50. PubMed ID: 22738913
[TBL] [Abstract][Full Text] [Related]
35. CD4 T-cell differentiation and inflammatory bowel disease.
Zenewicz LA; Antov A; Flavell RA
Trends Mol Med; 2009 May; 15(5):199-207. PubMed ID: 19362058
[TBL] [Abstract][Full Text] [Related]
36. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
[TBL] [Abstract][Full Text] [Related]
38. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.
Li Y; Yu C; Zhu WM; Xie Y; Qi X; Li N; Li JS
Mol Immunol; 2010 Sep; 47(15):2467-74. PubMed ID: 20615550
[TBL] [Abstract][Full Text] [Related]
39. Cytokines in inflammatory bowel disease.
Kmieć Z
Arch Immunol Ther Exp (Warsz); 1998; 46(3):143-55. PubMed ID: 9704146
[TBL] [Abstract][Full Text] [Related]
40. Mathematical model of the roles of T cells in inflammatory bowel disease.
Lo WC; Arsenescu RI; Friedman A
Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
